The moral problems with time-limited trials at the end-of-life, especially when clinicians and patients have different goals
Crossref DOI link: https://doi.org/10.1007/s00134-022-06831-w
Published Online: 2022-08-01
Published Print: 2022-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Donaldson, Thomas M. https://orcid.org/0000-0001-8257-2675
Text and Data Mining valid from 2022-08-01
Version of Record valid from 2022-08-01
Article History
Accepted: 14 July 2022
First Online: 1 August 2022
Declarations
:
: No competing interests or funding to declare.